Who we are?
Pharmaseed is Israel’s largest GLP-certified pre-clinical and early clinical CRO specializing in translational and regenerative studies.
Pharmaseed is equipped for the execution of NCE studies, biologics and medical-devices as well as conducting and following through from the development stage until first-in-man trials. These studies include safety and efficacy evaluation in various animal models in addition to complementary in-vitro/ex-vivo models and on-site human anatomy services.
Pharmaseed’s expertise in preclinical studies lies mostly in the following areas:
Cardio/vascular, Immuno-Oncology, Stem cell and Cellular Therapeutics, Microbiome research, Infectious Diseases, and CNS.
Founded in 2003, Pharmaseed is a GLP-certified contract research organization (CRO) providing pre-clinical, early clinical and consulting services for medical device, biotechnology and pharmaceutical companies. Pharmaseed also provides pre-formulation services for small and medium-size start-up companies as well as companies in the idea and feasibility stages.
Pharmaseed’s experienced team forms an efficient organization whose global reach includes a network of sponsors from the U.S., Europe, Canada and Israel. This network has enabled Pharmaseed to establish JV programs with pharmaceutical companies and academia as well as a top-tier S.A.B./K.O.L. panel from multinational bio-pharma companies.
All our services are priced at a competitive rate in comparison to European and U.S.- based companies.
Why work with us?
Safety & ADME
Whether your compound is an original small molecule or bioequivalent generic, injectable large molecule or biosimilar – our experts are true specialists.
Our services support an array of therapeutic disciplines
Cannabis based therapy
Cell & Gene based Therapy
Our services utilize various animal species